Notifiable Interest

Proteome Sciences PLC ("the Company") Notifiable Interest A form TR-1 containing the following information has been received by the Company. TR-1 notification of major interests in shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Proteome Sciences PLC 2. Reason for the notification An acquisition or disposal of voting rights 3. Full name of person(s) subject to the notification obligation: Sanofi-Aventis Deutschland GmbH 4. Full name of shareholder(s) (if different from 3): N/A 5. Date of the transaction (and date on which the threshold is crossed or reached if different): 11 July 2007 6. Date on which issuer notified: 12 July 2007 7. Threshold(s) that is/are crossed or reached: 11% 8. Notified details: A: Voting rights attached to shares Class/type Situation previous to Resulting situation after the triggering of shares Triggering transaction transaction if possible Notification required under DTR transitional using ISIN provision 7 CODE Number of Number of Number of Number of voting % of voting Shares Voting shares rights rights Rights Direct Direct Indirect Direct Indirect GB0003104196 14,982,811 14,982,811 13,663,380 13,663,380 10.39% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting rights that may % of financial date Conversion be acquired if the instrument is voting instrument Period/ Date exercised/converted N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 13,663,380 10.39% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: N/A 10. Name of the Proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: Juergen Blieke or Reiner May 15. Contact telephone number: 0049 69 305 4703 or 0049 69 305 80202
UK 100

Latest directors dealings